Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-006-0149-4PMID 16767486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

  2005cited by this paper
• Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome.

  2005cited by this paper
• Lymphocyte surge as a marker for immunorestitution disease due to Pneumocystis jiroveci pneumonia in HIV-negative immunosuppressed hosts

  2004cited by this paper
• Current Epidemiology of Pneumocystis Pneumonia

  2004cited by this paper
• Echinocandin antifungal drugs.

  2003cited by this paper
• Glucocorticoids and invasive fungal infections.

  2003cited by this paper
• Analysis of Underlying Diseases and Prognosis Factors Associated with Pneumocystis carinii Pneumonia in Immunocompromised HIV-Negative Patients

  2002cited by this paper
• Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres

  2002cited by this paper
• Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study.

  2002cited by this paper
• Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.

  2002cited by this paper
• Pneumocystis carinii pneumonia in patients without HIV infection.

  2001cited by this paper
• Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

  2001cited by this paper
• Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.

  2000cited by this paper
• Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.

  2000influential reference
• Prophylactic Effect of FK463, a Novel Antifungal Lipopeptide, against Pneumocystis carinii Infection in Mice

  2000cited by this paper
• Pneumocystis carinii pneumonia.

  1999cited by this paper
• Viral and Pneumocystis carinii infections of the lung in the immunocompromised host.

  1999cited by this paper
• Efficacy of MK-991 (L-743,872), a Semisynthetic Pneumocandin, in Murine Models ofPneumocystis carinii

  1998cited by this paper
• Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia.

  1998cited by this paper
• Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy.

  1996cited by this paper
• Diagnosis of Pneumocystis carinii pneumonia. How invasive

  1994cited by this paper
• Diagnosis of Pneumocystis carinii pneumonia. How invasive?

  1994cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence

  1993cited by this paper
• Pneumocystis carinii pneumonia in patients without AIDS.

  1993cited by this paper
• Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital.

  1992influential reference
• Pneumocystis carinii pneumonia among patients with neoplastic disease.

  1992cited by this paper
• Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.

  1990cited by this paper
• Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

  1990cited by this paper
• Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS

  1989cited by this paper
• Diagnosis of Pneumocystis carinii pneumonia. Roentgenographic-pathologic correlates based on fiberoptic bronchoscopy specimens from patients with the acquired immunodeficiency syndrome.

  1986cited by this paper
• Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.

  1984cited by this paper
• The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation.

  1979cited by this paper
• Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features.

  1976cited by this paper
• Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features.

  1974cited by this paper

• The Evolution of Pneumocystis jirovecii Pneumonia Prophylaxis for Pediatric Patients With Extracranial Solid Tumors: A Review of Historical Insights and Future Directions

  2026cites this paper
• Aerosolized Pentamidine Is an Effective Prophylaxis for Pneumocystis jiroveci Pneumonia in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

  2026cites this paper
• Pneumocystis jirovecii infection in autologous hematopoietic stem cell transplantation.

  2026cites this paper
• International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

  2024cites this paper
• Pneumocystis jirovecii pneumonia secondary to chronic steroid use: An uncommon cause of pneumocystis pneumonia

  2024cites this paper
• Cytomegalovirus and Pneumocystis jirovecii co-infection pneumonia as an initial presentation of HIV infection

  2024cites this paper
• Incidence and Temporal Dynamics of Combined Infections in SARS-CoV-2-Infected Patients With Risk Factors for Severe Complications

  2024cites this paper
• Late‐onset Pneumocystis jirovecii pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis

  2023cites this paper
• [Clinical characteristics and CT findings of Pneumocystis Jirovecii pneumonia in 46 cases with hematological diseases].

  2023cites this paper
• International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update

  2023cites this paper
• Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma

  2023cites this paper
• Relationship between clinical features and droplet digital PCR copy number in non-HIV patients with pneumocystis pneumonia

  2023cites this paper
• How to diagnose and treat a non-HIV patient with Pneumocystis jirovecii pneumonia (PCP)?

  2023cites this paper
• A comprehensive clinical guide for Pneumocystis jirovecii pneumonia: a missing therapeutic target in HIV-uninfected patients

  2022cites this paper
• Incidence of Pneumocystis jirovecii pneumonia (PJP) in patients receiving BTK inhibitors who did not receive PJP prophylaxis

  2022cites this paper
• Investigation of Pneumocystis jirovecii in Lung Cancer Patients with the Nested PCR Method.

  2022cites this paper
• Myocardial Infarction As the Initial Presentation of Rituximab-Induced Interstitial Lung Disease: A Case Report

  2022cites this paper
• Changing Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Host Factors and Outcomes in Hospitalizations for Pneumocystis Jirovecii Pneumonia in the United States.

  2021cites this paper
• Pneumocystis pneumonia

  2021cites this paper
• Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center

  2021cites this paper
• Recent epidemiology of Pneumocystis pneumonia in Japan.

  2020cites this paper
• Diagnostic accuracy of serum (1-3)-β-D-Glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.

  2020cites this paper
• Epidemiology of fungal infections: What, where, and when

  2019cites this paper
• Serial change in serum biomarkers during treatment of Non-HIV Pneumocystis pneumonia.

  2019cites this paper
• Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.

  2019cites this paper
• Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study

  2019cites this paper
• Therapy and Management of Pneumocystis jirovecii Infection

  2018cites this paper
• Infections in Allogeneic Stem Cell Transplantation

  2018cites this paper
• Infections fongiques compliquant les hémopathies et les greffes de cellules souches : incidence, facteurs de risque, mortalité, et développement de scores prédictifs décisionnels pour améliorer la pertinence des prophylaxies

  2018cites this paper
• A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection

  2017cites this paper
• Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature

  2017cites this paper
• Pulmonary co‐infections by Pneumocystis jirovecii and Aspergillus fumigatus in non‐HIV patients: A report of two cases and literature review

  2017cites this paper
• Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis

  2017cites this paper
• A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers.

  2017cites this paper
• Clinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice

  2016cites this paper
• Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients

  2016cites this paper
• ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.

  2016cites this paper
• Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients

  2016cites this paper
• Risks and Epidemiology of Infections After Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Management of Acute Respiratory Failure in Patients With Hematological Malignancy

  2016cites this paper
• Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

  2016cites this paper
• Clinical Characteristics, Prognostic Factors and Influence of Prophylaxis in Children with Pneumocystis jirovecii Pneumonia

  2016cites this paper
• Pneumonia After Hematopoietic Stem Cell Transplantation

  2016cites this paper
• Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation

  2016influential citation
• The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR® analysis

  2015cites this paper
• Czynniki ryzyka, obraz kliniczny oraz profilaktyka i leczenie zakażeń Pneumocystis jirovecii u dzieci z chorobami hemato-onkologicznymi: rekomendacje ECIL

  2015cites this paper
• Évaluation diagnostique et intérêt en pratique clinique de la PCR temps réel pour différencier colonisation et maladie chez des patients avec PCR positive à Pneumocystis jirovecii : une étude prospective monocentrique

  2014cites this paper
• [Pneumocystis jiroveci pneumonia: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients].

  2014cites this paper
• Infections associated with solid malignancies.

  2014cites this paper
• Características clínicas, diagnósticas y pronósticas de pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus de inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología

  2014cites this paper
• Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience

  2014cites this paper
• Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.

  2014influential citation
• Respiratory tract infections in the immunocompromised

  2013cites this paper
• Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.

  2013cites this paper
• Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis.

  2013cites this paper
• Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies

  2012cites this paper
• Fever and Granulocytopenia

  2012cites this paper
• Pneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer

  2012cites this paper
• A case of Pneumocystis pneumonia during receiving medication by steroid for autoimmune hepatitis

  2012cites this paper
• Fungal infections in transplant and oncology patients.

  2011cites this paper
• Respiratory Infections in Patients with Hematological Malignancies

  2011cites this paper
• Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools

  2011cites this paper
• Diagnosis and management of infectious complications in critically ill patients with cancer.

  2010influential citation
• 80 – Infections in Hematopoietic Stem Cell Transplant Recipients

  2010cites this paper
• Reversed halo sign in pneumocystis pneumonia: a case report

  2010cites this paper
• Fungal infections in transplant and oncology patients.

  2010cites this paper
• Advances in HIV care and treatment in resource-poor countries

  2009cites this paper
• Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantation.

  2009cites this paper
• Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors.

  2009cites this paper
• Invasive aspergillosis in glucocorticoid-treated patients.

  2009cites this paper
• Lung infections after cancer chemotherapy.

  2008cites this paper
• VIRAL INFECTIONS IN CHILDREN WITH CANCER

  2008cites this paper
• Diagnostic features and resistance testing for Pneumocystis jirovecii 1

  2008cites this paper
• Cavitary Pulmonary Disease

  2008cites this paper
• Diagnostik und Resistenztestung bei Pneumocystis jirovecii / Diagnostic features and resistance testing of Pneumocystis jirovecii

  2008cites this paper
• Pneumocystose chez les patients d'onco-hématologie : est-ce inévitable ?

  2007cites this paper
• Advances in pathogenesis and management of sepsis

  2007cites this paper
• [Pneumocystis jiroveci pneumonia in patients with cancer: is it unavoidable?].

  2007cites this paper
• Editorial introductions vii Editorial introductions. Nosocomial and hospital-related infections 345 Advances in pathogenesis and management of sepsis.

  2007cites this paper
• Management of Pneumocystis jiroveci Pneumonia in Children Receiving Chemotherapy

  2007cites this paper